December 15, 2020. € 9.5 Mio EU Innovative Medicines Initiative (IMI) grant "T2EVOLVE" awarded to an international consortium of 27 partners, including T-CURX
September 9, 2020. T-CURX obtains exclusive license from the University of Würzburg, Germany, for a portfolio of 8 patent families, covering novel CAR-T cell technologies and products
